The rarely occurring disease of endolymphatic stromal myosis is discussed by means of an impressive case. The cells of this semimalignant tumour resemble those of the endometrium, but it is not clear whether this tumour can be derived histogenetically from the endometrium or from the cells of the duct of Müller (ductus paramesonephricus) or from pericytal cells. The histological pattern of the tumour, which is characterized by the uniformity of small spindle-like oval cells without remarkable mitotic activity, and by a lack of atypical criteria, does not permit any prognosis in respect of its clinical behaviour. According to the rare references in literature, the clinical course is usually protracted with occasional occurrence of metastases and relapses. The therapy consists of radiotherapy and administration of progesterone. The case described in this article is a clinically malignant one because of disseminated metastases and relapse following initially successful therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1037287DOI Listing

Publication Analysis

Top Keywords

stromal myosis
8
semimalignant tumour
8
[endolymphatic stromal
4
myosis rare
4
rare semimalignant
4
tumour
4
tumour author's
4
author's transl]
4
transl] rarely
4
rarely occurring
4

Similar Publications

Purpose: Endometrial cancer (EC) ranks as one of the most prevalent gynecological malignancies globally. The presence and role of stromal tumor-infiltrating lymphocytes (TILs) in the tumor microenvironment have garnered interest due to their prognostic and therapeutic potential. This study aimed to evaluate the association between stromal TILs and various clinicopathological parameters in EC.

View Article and Find Full Text PDF

Background: Ewing sarcoma is an EWSR1-rearranged aggressive malignancy that occurs commonly in bone and has small round blue cell morphology. A diagnostic challenge is presented in the cases of extraskeletal Ewing sarcoma involving solid organs, such as the uterus.

Case Report And Brief Literature Review: We present the case of a 54-year-old female with a large pelvic mass connected to the uterine cornua and retroperitoneal soft tissue.

View Article and Find Full Text PDF

Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review).

Mol Med Rep

March 2025

Key Laboratory for Experimental Teratology of Ministry of Education, Department of Histology and Embryology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China.

Endometriosis (EM) is a chronic inflammatory disease that is one of the most common causes of gynecological systemic lesions in women before menopause. The most representative histological feature of EM is that the endometrium appears outside of the uterine cavity, often in the ovary. Although it is generally accepted that the epithelial and stromal cells of the ectopic endometrium are not malignant, they still have numerous similarities to malignant tumors, including considerable changes to the immune microenvironment (immune monitoring disorder), the creation of a specific hormone environment, high levels of oxidative stress, chronic inflammation and abnormal immune cell regulation.

View Article and Find Full Text PDF

Background: Low-grade endometrial stromal sarcoma (LG-ESS) is a rare uterine malignancy characterized by its complex tumor microenvironment (TME) and high recurrence rates, posing challenges to accurate prognosis and effective treatment. Identifying prognostic biomarkers is essential for improving patient stratification and guiding therapeutic strategies.

Methods: Using single-cell transcriptome analysis combined with H&E and multiplex immunofluorescence staining, we identified a subpopulation of tumor cells in LG-ESS and further validated the association of this subpopulation and its characteristic genes with LG-ESS prognosis by molecular characterization and bulk transcriptome data.

View Article and Find Full Text PDF

Uterine endometrioid carcinoma (UEC) has well-defined morphologic features that carry prognostic significance and guide treatment. In addition to the well-known features, tumor budding (TB), poorly differentiated clusters (PDCs), and amount of stroma within the invasive front are associated with a poor prognostic outcome in many carcinomas. Here, we evaluate TB, PDCs, and the stroma percentage in UEC and correlate these findings with morphologic features known to be associated with a poor clinical outcome and with recurrence-free survival (RFS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!